Literature DB >> 29134169

Age and Tumor Volume Predict Growth of Carotid and Vagal Body Paragangliomas.

Berdine L Heesterman1, Lisa M H de Pont1, Berit M Verbist2, Andel G L van der Mey1, Eleonora P M Corssmit3, Frederik J Hes4, Peter Paul G van Benthem1, Jeroen C Jansen1.   

Abstract

Objective  Treatment for head and neck paragangliomas (HNGPL) can be more harmful than the disease. After diagnosis, an initial period of surveillance is often indicated, and surgery or radiotherapy is reserved for progressive disease. With the aim to optimize this "wait and scan" strategy, we studied growth and possible predictors. Design  A retrospective cohort study was conducted. Setting  This study was conducted at a tertiary referral center for patients with HNGPL. Methods  Tumor volume was estimated for 184 SDHD -related carotid and vagal body paragangliomas using sequential magnetic resonance imaging. Cox regression was used to study predictors of tumor growth. Results  The estimated fraction of growing tumors ranged from 0.42 after 1 year of follow-up to 0.85 after 11 years. A median growth rate of 10.4 and 12.0% per year was observed for carotid and vagal body tumors, respectively. Tumor location, initial volume, and age ( p  < 0.05) were included in our prediction model. The probability of growth decreased with increasing age and volume, indicating a decelerating growth pattern. Conclusions  We created a prediction model (available online), enabling a more individualized "wait and scan" strategy. The favorable natural course of carotid and vagal body paragangliomas was confirmed; although with long follow-up growth will be observed in most cases.

Entities:  

Keywords:  SDHD; carotid body tumors; growth; paragangliomas; prediction; succinate dehydrogenase; vagal body

Year:  2017        PMID: 29134169      PMCID: PMC5680030          DOI: 10.1055/s-0037-1604347

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  25 in total

1.  Radiotherapy for benign head and neck paragangliomas: a 45-year experience.

Authors:  Philip Gilbo; Christopher G Morris; Robert J Amdur; John W Werning; Peter T Dziegielewski; Jessica Kirwan; William M Mendenhall
Journal:  Cancer       Date:  2014-07-24       Impact factor: 6.860

2.  The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas.

Authors:  Sampath Chandra Prasad; Hassen Ait Mimoune; Flavia D'Orazio; Marimar Medina; Andrea Bacciu; Renato Mariani-Costantini; Paolo Piazza; Mario Sanna
Journal:  Otol Neurotol       Date:  2014-06       Impact factor: 2.311

3.  Estimating Tumor Growth Rates In Vivo.

Authors:  Anne Talkington; Rick Durrett
Journal:  Bull Math Biol       Date:  2015-10       Impact factor: 1.758

4.  Evaluating Random Forests for Survival Analysis using Prediction Error Curves.

Authors:  Ulla B Mogensen; Hemant Ishwaran; Thomas A Gerds
Journal:  J Stat Softw       Date:  2012-09       Impact factor: 6.440

5.  Growth dynamics of untreated glioblastomas in vivo.

Authors:  Anne Line Stensjøen; Ole Solheim; Kjell Arne Kvistad; Asta K Håberg; Øyvind Salvesen; Erik Magnus Berntsen
Journal:  Neuro Oncol       Date:  2015-03-10       Impact factor: 12.300

Review 6.  Vagal paragangliomas.

Authors:  J C Sniezek; J L Netterville; A N Sabri
Journal:  Otolaryngol Clin North Am       Date:  2001-10       Impact factor: 3.346

Review 7.  Head and Neck Paragangliomas: An Update on Evaluation and Management.

Authors:  Michael G Moore; James L Netterville; William M Mendenhall; Brandon Isaacson; Brian Nussenbaum
Journal:  Otolaryngol Head Neck Surg       Date:  2016-02-09       Impact factor: 3.497

8.  Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy.

Authors:  Carlos Suárez; Juan P Rodrigo; William M Mendenhall; Marc Hamoir; Carl E Silver; Vincent Grégoire; Primož Strojan; Hartmut P H Neumann; Rupert Obholzer; Christian Offergeld; Johannes A Langendijk; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-19       Impact factor: 2.503

9.  Resection of carotid body tumors: results of an evolving surgical technique.

Authors:  Koen E A van der Bogt; Mark-Paul F M Vrancken Peeters; Jary M van Baalen; Jaap F Hamming
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

Review 10.  15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5.

Authors:  Diana E Benn; Bruce G Robinson; Roderick J Clifton-Bligh
Journal:  Endocr Relat Cancer       Date:  2015-08       Impact factor: 5.678

View more
  4 in total

1.  Mathematical Models for Tumor Growth and the Reduction of Overtreatment.

Authors:  Berdine L Heesterman; John-Melle Bokhorst; Lisa M H de Pont; Berit M Verbist; Jean-Pierre Bayley; Andel G L van der Mey; Eleonora P M Corssmit; Frederik J Hes; Peter Paul G van Benthem; Jeroen C Jansen
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-23

2.  Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers.

Authors:  Berdine L Heesterman; Lisa M H de Pont; Andel Gl van der Mey; Jean-Pierre Bayley; Eleonora Pm Corssmit; Frederik J Hes; Berit M Verbist; Peter Paul G van Benthem; Jeroen C Jansen
Journal:  Eur J Hum Genet       Date:  2018-05-18       Impact factor: 4.246

3.  Usefulness of preoperative three-dimensional volumetric analysis of carotid body tumors.

Authors:  Rodrigo Lozano-Corona; Javier E Anaya-Ayala; Ricardo Martínez-Martínez; Sabsil López-Rocha; Melisa A Rivas-Rojas; Adriana Torres-Machorro; Hugo Laparra-Escareno; Carlos A Hinojosa
Journal:  Neuroradiology       Date:  2018-09-10       Impact factor: 2.804

Review 4.  Contemporary management of paragangliomas of the head and neck.

Authors:  Eoin F Cleere; Julie Martin-Grace; Adrien Gendre; Mark Sherlock; James P O'Neill
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.